GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $391,317 | +611332.8% | 13,202 | -2.4% | 0.00% | -71.4% |
| Q2 2023 | $64 | -100.0% | 13,532 | -84.7% | 0.01% | -78.1% |
| Q3 2022 | $3,790,000 | -4.2% | 88,717 | +4.1% | 0.03% | 0.0% |
| Q2 2022 | $3,957,000 | +546.6% | 85,230 | +874.9% | 0.03% | +700.0% |
| Q1 2022 | $612,000 | -42.5% | 8,742 | -18.9% | 0.00% | -33.3% |
| Q2 2021 | $1,065,000 | -39.7% | 10,778 | -3.5% | 0.01% | -45.5% |
| Q1 2021 | $1,767,000 | -1.9% | 11,167 | -0.8% | 0.01% | 0.0% |
| Q4 2020 | $1,801,000 | +47.5% | 11,260 | -3.5% | 0.01% | +22.2% |
| Q3 2020 | $1,221,000 | +25.6% | 11,664 | -0.6% | 0.01% | +28.6% |
| Q2 2020 | $972,000 | +15.6% | 11,737 | +6.3% | 0.01% | -12.5% |
| Q1 2020 | $841,000 | -6.5% | 11,041 | -2.9% | 0.01% | +14.3% |
| Q4 2019 | $899,000 | +6.0% | 11,373 | -8.9% | 0.01% | 0.0% |
| Q3 2019 | $848,000 | -16.1% | 12,481 | +14.0% | 0.01% | -12.5% |
| Q2 2019 | $1,011,000 | – | 10,949 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |